BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 429089)

  • 1. Syntheses and biological activities of methoxinine-analogues of the C-terminal octapeptide of cholecystokinin-pancreozymin.
    Gillessen D; Trzeciak A; Müller RK; Studer RO
    Int J Pept Protein Res; 1979 Feb; 13(2):130-6. PubMed ID: 429089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate.
    Bodanszky M; Martinez J; Priestley GP; Gardner JD; Mutt V
    J Med Chem; 1978 Oct; 21(10):1030-5. PubMed ID: 722712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of the C-terminal octapeptide of cholecystokinin, of three of its analogues and of caerulein in the dog.
    Meyer FD; Gyr K; Kayasseh L; Jeker L; Wall M; Trzeciak A; Gillessen D
    Experientia; 1980 Apr; 36(4):434-6. PubMed ID: 7379916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of gastrin I, secretin, and cholecystokinin on gallbladder smooth muscle.
    Ryan J; Cohen S
    Am J Physiol; 1976 Mar; 230(3):553-6. PubMed ID: 1266957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifying effect of bradykinin on motor activity in the guinea-pig gall bladder.
    Stasiewicz J; Szalaj W; Gabryelewicz A
    Clin Exp Pharmacol Physiol; 1977; 4(6):561-4. PubMed ID: 589871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of [27-Tyr]-cholecystokinin-pancreozymin (CCK-PZ).
    Yajima H; Mori Y; Kiso Y; Koyama K; Tobe T; Setoyama M; Adachi H; Kanno T; Saito A
    Chem Pharm Bull (Tokyo); 1976 May; 24(5):1110-3. PubMed ID: 1021264
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholecystokinin (pancreozymin). 5. Hormonally active desamino derivative of Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2.
    Bodanszky M; Martinez J; Walker M; Gardner JD; Mutt V
    J Med Chem; 1980 Jan; 23(1):82-5. PubMed ID: 6153722
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.
    Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V
    Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue.
    Sugg EE; Serra M; Shook JE; Yamamura HI; Burks TF; Korc M; Hruby VJ
    Int J Pept Protein Res; 1988 Jun; 31(6):514-9. PubMed ID: 2457563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cholecystokinin-like peptide in crude substance P from human and bovine brain.
    Zetler G; Cannon D; Powell D; Skrabanek P; Vanderhaeghen JJ
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):28-41. PubMed ID: 485701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin-like activities in guinea pigs and in dogs of the C-terminal octapeptide (SQ 19,844) of cholecystokinin.
    Rubin B; Engel SL; Drungis AM; Dzelzkalns M; Grigas EO; Waugh MH; Yiacas E
    J Pharm Sci; 1969 Aug; 58(8):955-9. PubMed ID: 5344529
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of cholecystokinin, gastrin, and related peptides on coho salmon gallbladder contraction in vitro.
    Vigna SR; Gorbman A
    Am J Physiol; 1977 May; 232(5):E485-91. PubMed ID: 860759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33.
    Solomon TE; Yamada T; Elashoff J; Wood J; Beglinger C
    Am J Physiol; 1984 Jul; 247(1 Pt 1):G105-11. PubMed ID: 6204542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on isolated intestinal preparations and gallbladders of guinea pigs and mice.
    Zetler G
    Peptides; 1984; 5(4):729-36. PubMed ID: 6093075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of various sex steroids on cholecystokinin- and KCl-induced tension in female guinea pig gallbladder strips.
    Kline L; Karpinski E
    Gen Comp Endocrinol; 2013 May; 185():37-43. PubMed ID: 23399969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin inhibits cholecystokinin-induced contraction of isolated gallbladder smooth muscle cells.
    Yamasaki T; Chijiiwa K; Chijiiwa Y
    J Surg Res; 1995 Dec; 59(6):743-6. PubMed ID: 8538175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors.
    von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H
    Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan replacement in the C-terminal octapeptide of CCK-PZ. Syntheses of six peptide analogues bearing tryptophan congeners.
    Rajh HM; Mariman EC; Tesser GI; Nivard RJ
    Int J Pept Protein Res; 1980 Mar; 15(3):200-10. PubMed ID: 7380604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33.
    Martinez J; Winternitz F; Bodanszky M; Gardner JD; Walker MD; Mutt V
    J Med Chem; 1982 May; 25(5):589-93. PubMed ID: 6177857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between muscular receptors and neural receptors for cholecystokinin-octapeptide in the guinea-pig gallbladder.
    Takahashi T; Yamamura T; Kusunoki M; Kantoh M; Ishikawa Y; Utsunomiya J
    Eur J Pharmacol; 1987 Apr; 136(2):255-8. PubMed ID: 3595725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.